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Abstract. 
 
Balbiani ring (BR) pre-mRNP particles reside 
 
in the nuclei of salivary glands of the dipteran 
 
Chirono-
mus tentans
 
 and carry the message for giant-sized sali-
vary proteins. In the present study, we identify and 
characterize a new protein component in the BR ribo-
nucleoprotein (RNP) particles, designated hrp23. The 
protein with a molecular mass of 20 kD has a single 
RNA-binding domain and a glycine-arginine-serine–rich 
auxiliary domain. As shown by immunoelectron micros-
copy, the hrp23 protein is added to the BR transcript 
concomitant with transcription, is still present in the BR 
particles in the nucleoplasm, but is absent from the BR 
particles that are bound to the nuclear pore complex or 
are translocating through the central channel of the com-
plex. Thus, hrp23 is released just before or at the binding 
of the particles to the nuclear pore complex. It is noted 
that hrp23 behaves differently from two other BR RNP 
proteins earlier studied: hrp36 and hrp45. These proteins 
both reach the nuclear pore complex, and hrp36 even ac-
companies the RNA into the cytoplasm. It is concluded 
that each BR RNA-binding protein seems to have a spe-
cific flow pattern, probably related to the particular role 
of the protein in gene expression.
Key words: hnRNP protein • nonshuttling proteins • 
nucleocytoplasmic transport • Balbiani rings • nucleolus
 
I
 
mmediately
 
 upon synthesis, pre-messenger RNA
 
(pre-mRNA)
 
1
 
 molecules associate with proteins to
form heterogeneous nuclear ribonucleoprotein parti-
cles (hnRNPs) (Dreyfuss et al., 1993). The predominant
hnRNP proteins remain bound to the transcripts while
these reside in the nucleus. When the processed transcripts
leave the nucleus through the nuclear pores, some of the
hnRNP proteins are displaced from the transcripts, while
others accompany the transcripts into the cytoplasm (Pi-
nol-Roma and Dreyfuss, 1992; Daneholt, 1997). For a long
time, no specific function could be assigned to the hnRNP
proteins, but substantial information has now accumulated
suggesting that they play crucial roles in pre-mRNA splic-
ing as well as in the transport of mature mRNA into the
cytoplasm.
The hnRNP proteins are among the most abundant in
the cell nucleus (Michael et al., 1995
 
b
 
). In human, the
hnRNP particles contain more than 20 major protein spe-
cies, designated hnRNP A1 to hnRNP U (Pinol-Roma et al.,
1988). In 
 
Drosophila
 
, more than 10 of the predominant
hnRNP proteins have been found and characterized, some
of them showing high homology to the human proteins
(e.g., Haynes et al., 1990; Amero et al., 1991; Matunis et al.,
1992). The hnRNP proteins have a modular structure con-
taining one or more RNA-binding motifs and an auxiliary
domain (Dreyfuss et al., 1993). The predominant RNA-
binding domain (RBD) is composed of 90–100 amino ac-
ids and is usually called the RNP consensus RBD or the
RNA recognition motif; within this sequence, there is a
highly conserved octapeptide, RNP-1, and a hexapeptide,
RNP-2. Several of the most abundant hnRNP proteins,
e.g., hnRNP A1, have a glycine-rich auxiliary domain and
are designated RBD-Gly proteins (Dreyfuss et al., 1993).
The hnRNP proteins are added to the growing RNA
transcript concomitant with transcription (Economides
and Pederson, 1983; Matunis et al. 1993; Wurtz et al.,
1996), and an RNP fibril is immediately formed (Miller
and Bakken, 1972; Skoglund et al., 1983; Fakan, 1994). If
the transcript is long, the fibril is further folded into a com-
pact RNP particle (Monneron and Bernhard, 1969; Sko-
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glund et al., 1986). The packing of the transcript into an
RNP fibril or RNP particle could be important to ensure
efficient transport and a minimum of irrelevant interac-
tions and entanglements. Furthermore, the RNP complex
is organized in a nonrandom manner. The various hnRNP
proteins bind to RNA in a sequence-dependent manner
(for review see Dreyfuss et al., 1993) and are, therefore,
likely to appear in a specific arrangement along an hnRNA
molecule. In addition, when the basic RNP fibril is further
folded, the RNP particles attain a characteristic shape (Mal-
colm and Sommerville, 1974; Skoglund et al., 1986). Thus,
the RNA molecule is organized in a specific way in the RNP
complexes, presumably exposing certain sequences for
molecular interactions while others are likely to be hidden
in the complex.
The hnRNP proteins are important to accomplish
proper splicing of pre-mRNA. The splicing takes place on
the growing RNP complex (Osheim et al., 1985; Beyer and
Osheim, 1988; LeMaire and Thummel, 1990; Baurén and
Wieslander, 1994) or on the completed RNP product re-
leased from the template (Nevins, 1983; see also Baurén
and Wieslander, 1994). It was shown early on that antibod-
ies to hnRNP proteins can block splicing in vitro, suggest-
ing that the hnRNP proteins are involved in the splicing
reaction (Choi et al., 1986; Sierakowska et al., 1986).
There is growing evidence suggesting that SR proteins, an
extensively studied family of splicing factors, could also be
regarded as constitutive components of the RNP complex
rather than as spliceosome components that are assembled
and disassembled in conjunction with splicing (Alzhanova-
Ericsson et al., 1996; see also Cáceres et al., 1998). Like the
classical hnRNP proteins, the SR proteins contain one or
more RNA-binding domains of the RNP consensus type
and an auxiliary domain (Birney et al., 1993; Fu, 1995).
The auxiliary domain of the SR proteins is characterized
by a series of serine-arginine dipeptides (SR domain). The
SR proteins are essential splicing factors, which can often
also regulate alternative splicing (for reviews see Fu, 1995;
Manley and Tacke, 1996; Valcárcel and Green, 1996). They
not only take part in establishing the early commitment
complex but also participate in later stages of the splicing
process. The main role of the SR proteins seems to be to
form molecular bridges between essential components of
the spliceosome. It is interesting to note that hnRNP A/B
proteins and SR proteins act antagonistically in the regula-
tion of alternative splicing in vitro (Mayeda and Krainer,
1992; Mayeda et al., 1994). Presumably, the various SR
proteins have different functions and/or targets during
splicing (e.g., Manley and Tacke, 1996), and at least some
of them are likely to play a regulatory role during develop-
ment (Ring and Lis, 1994).
The hnRNP proteins are also directly involved in the
transport process. It has been revealed that hnRNP A1,
which shuttles between the nucleus and the cytoplasm (Pi-
nol-Roma and Dreyfuss, 1992), contains a nuclear export
signal (NES) (Michael et al., 1995
 
a
 
). It has also been dem-
onstrated for an hnRNP A1 homologue that it leaves the
nucleus still associated with mRNA (Visa et al., 1996
 
a
 
).
Taken together, this information strongly supports the
proposition that the export signal in hnRNP A1 mediates
not only the export of A1 itself but also the exit of the en-
tire mRNP complex (Pinol-Roma and Dreyfuss, 1992).
Recent microinjection experiments have further strength-
ened the notion that the A1 NES plays a role in the export
of mRNA; however, the export of other classes of RNA
remains unaffected (Izaurralde et al., 1997
 
a
 
). It seems
likely that the NES domain of A1 interacts with a soluble
export receptor because such receptors, designated ex-
portins and involved in the export of proteins with leucine-
rich NESs (including the Rev protein), have recently been
identified (Fornerod et al., 1997; Fukuda et al., 1997; Stade
et al., 1997). An A1-interacting protein called transportin
mediates the reentry of A1 into the nucleus (Pollard et al.,
1996; Fridell et al., 1997), but it is uncertain whether it is
also the RNP export receptor looked for (Izaurralde et al.,
1997
 
a
 
,
 
b
 
; Siomi et al., 1997). It should be added that a puta-
tive export signal different from the A1 NES has recently
been identified in hnRNP K (Michael et al., 1997). Be-
cause hnRNP A1 and hnRNP K are likely to be bound to
the same transcript and both in many copies, the transport
machinery for mRNP could be quite complex.
Finally, the hnRNP proteins could be involved in active
retention of mRNAs in the nucleus. The nonshuttling
hnRNP proteins, e.g., hnRNP C1, C2, and U (Pinol-Roma
and Dreyfuss, 1991, 1992), are stripped off from RNP par-
ticles before mRNA is transported into the cytoplasm. A
78–amino acid–long nuclear retention signal has been dis-
covered in the auxiliary domain of hnRNP C1 (Nakielny
and Dreyfuss, 1996). This nuclear retention signal can
override nuclear export signals in the shuttling hnRNP
proteins, and therefore, the nonshuttling proteins have to
be actively removed from the hnRNP complex before the
nucleocytoplasmic translocation.
The hnRNP complexes bind to and pass through the nu-
clear pore complex (NPC) in an ordered, multistep pro-
cess (Daneholt, 1997). The NPC consists of a spoke assem-
bly sandwiched between a nuclear and a cytoplasmic ring
(for recent review see Panté and Aebi, 1996). In the center
of the NPC, there is a plug containing a central, transport-
mediating channel. In addition, nuclear fibers extend from
the nuclear ring into the nucleoplasm, forming a well-
defined basket structure, and cytoplasmic fibers anchored
in the cytoplasmic ring reach into the cytoplasm. The RNP
complexes bind to the nuclear basket, are transferred to
the entrance of the central channel, and translocate
through the channel (Daneholt, 1997; Panté et al., 1997).
On the cytoplasmic side, they enter the cytoplasm with no
obvious contact with the cytoplasmic fibers. Before or
in conjunction with the passage through the NPC, the
hnRNP complexes lose the nonshuttling proteins (Pinol-
Roma and Dreyfuss, 1992; Alzhanova-Ericsson et al.,
1996), while the shuttling ones seem to remain attached to
the RNA molecule (Visa et al., 1996
 
a
 
). Our knowledge of
the molecular structure of the NPC is rapidly increasing
(Doye and Hurt, 1997; Ohno et al., 1998), but there is still
only limited information at the molecular level on the na-
ture of the initial binding of the mRNP to the NPC and the
further translocation of the particle through the NPC.
To further elucidate the structure of the hnRNP com-
plexes and the function of the various hnRNP proteins
involved, it is a great advantage to be able to analyze a
specific pre-mRNP complex. The Balbiani ring (BR) pre-
mRNP particles in the salivary glands of the dipteran 
 
Chi-
ronomus tentans
 
 offer such a possibility (Daneholt, 1997). 
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By electron microscopy, it is possible to follow how the
BR pre-mRNP particle is assembled along a gene, and
how the released BR pre-mRNP particle is transported in
the nucleoplasm to and through a nuclear pore. It has been
possible to define a series of discrete steps during the pas-
sage of the particle through the NPC and to reveal drastic
conformational changes of the particle during the translo-
cation. Furthermore, the fate of defined hnRNP proteins
in the BR particles can be investigated by immunoelectron
microscopy. Two hnRNP proteins, hrp36 and hrp45, have
been analyzed in detail (Wurtz et al., 1996). The hrp36
protein shows high homology to human hnRNP A1 and
 
Drosophila
 
 hrp40 (Visa et al., 1996
 
a
 
). It is being added to
BR particles concomitant with transcription and accompa-
nies the BR-mRNA through the nuclear pore and ends up
with mRNA in polysomes in cytoplasm. The hrp45 protein
is an SR protein and is similar to the human splicing factor
SF2/ASF and 
 
Drosophlia
 
 SRp55/B52 (Alzhanova-Erics-
son et al., 1996). This protein is confined to the nucleus
and is released when the particle enters the central chan-
nel of the nuclear pore complex.
In the present study, we have identified a third hnRNP
protein in the BR particles, hrp23, and determined its fate.
This protein contains one RNA-binding domain and a
glycine-arginine-serine–rich auxiliary domain. It is being
added to the BR transcript concomitant with transcription
and is released from the BR particle just before or at the
binding of the particle to the nuclear pore complex, i.e.,
hrp23 is shed late but still clearly before hrp45, the non-
shuttling protein earlier studied. It seems likely, therefore,
that there is not a single protein-removal step at nucleocy-
toplasmic transport but rather a series of preparatory steps
before the actual translocation of the RNP particle
through the pore. We conclude that each hnRNP protein
seems to have a specific flow pattern during nucleocyto-
plasmic transport, presumably coupled to the particular
function of the protein. It should finally be added that un-
like hrp36 and hrp45, hrp23 is present also in the nucleoli.
 
Materials and Methods
 
Culturing Conditions and Drug Treatments
 
C
 
.
 
 tentans
 
 was cultured as described by Lezzi et al. (1981), and salivary
glands were isolated from fourth instar larvae. 
 
C
 
.
 
 tentans
 
 tissue culture
cells were grown in suspension at 24
 
8
 
C as previously described (Wyss,
1982). In actinomycin D treatments, the cells were first incubated for 30
min in fresh medium containing 50 
 
m
 
g/ml cycloheximide. The actinomycin
D was subsequently added to the culture at a final concentration of 5 
 
m
 
g/ml,
and the incubation continued for an additional 60 min. In all cases, control
cells were incubated in parallel in fresh medium without drugs.
 
Preparation of RNP Extract from C. tentans Tissue 
Culture Cells
 
The RNP extract was prepared as earlier described (Wurtz et al., 1996). In
short,
 
 C
 
.
 
 tentans 
 
tissue culture cells were washed in PBS (137 mM NaCl,
3 mM KCl, 8 mM Na
 
2
 
HPO
 
4
 
, and 2 mM NaH
 
2
 
PO
 
4
 
, pH 7.2), resuspended in
TNM (10 mM triethanolamine-HCl, pH 7.0, 100 mM NaCl, and 1 mM
MgCl
 
2
 
) containing 0.2% NP-40 and 0.1 mM PMSF, homogenized in a
glass tissue grinder with a tight-fitting pestle, and centrifuged at 2,000 
 
g
 
 for
5 min at 4
 
8
 
C. The pellet, containing the nuclei, was resuspended in TNM
provided with
 
 E
 
.
 
 coli 
 
tRNA (0.1 mg/ml), sonicated, and centrifuged at
7,000 
 
g
 
 for 10 min at 4
 
8
 
C. The supernatant, designated the RNP extract,
was used for immunoprecipitation of hnRNP complexes and for Western
blot analysis.
 
Generation of Monoclonal Antibody 1D3
 
The 1D3 antibody is a mouse mAb obtained from spleen cells of BALB/c
mice immunized with 
 
C
 
.
 
 tentans 
 
hnRNP proteins as follows:
 
Immunoprecipitation of hnRNP Complexes from C. tentans RNP Ex-
tract. 
 
hnRNP complexes were immunoprecipitated from the RNP extract
essentially as described by Wurtz et al. (1996). Tissue culture cells from
500 ml of medium were used to prepare 4 ml of the RNP extract (in
TNM). The RNP extract was supplemented with NP-40 to a final con-
centration of 0.1% and mAb 4F9 (an anti-hrp36 antibody) to 20 
 
m
 
g/ml.
The mixture was incubated at 4
 
8
 
C with gentle rotation. After 90 min of in-
cubation, 100 
 
m
 
l of rabbit anti–mouse immunoglobulin coupled to protein
A–Sepharose was added to the mixture, and the incubation continued at
4
 
8
 
C for an additional 90 min. The immunoglobulin–protein A–Sepharose
complex was prepared according to Wurtz et al. (1996). Once the incuba-
tion was finished, the Sepharose resin was sedimented, washed twice with
TNM containing 0.1% NP-40, and washed once with TNM. The immuno-
precipitated material was finally eluted from the resin with 0.5% SDS in
water. The eluted proteins were precipitated with cold acetone and resus-
pended in PBS. This procedure gave 25–50 
 
m
 
g of hnRNP proteins as
judged from Coomassie blue–stained SDS-PAGE gels.
 
Immunization of BALB/c Mice. 
 
The immunization was carried out fol-
lowing standard procedures as described by Harlow and Lane (1988). Ap-
proximately 15–20 
 
m
 
g of hnRNP proteins, dissolved in PBS, were mixed
with complete Freund adjuvant and injected intraperitoneally to BALB/c
mice. Three boost injections with the same amount of antigen in incom-
plete adjuvant were given in 2-wk intervals. 10 d after the last boost, the
sera of the immunized mice were tested by Western blot analysis to detect
antibodies against 
 
C
 
.
 
 tentans
 
 proteins. The mouse that gave the strongest
response received an intravenous injection of antigen in PBS without ad-
juvant.
 
Fusion and Screening of Suitable mAbs. 
 
3 d after the last injection, the
spleen of the immunized mouse was macerated, and the spleen cells were
fused with mouse myeloma Sp20 cells in the presence of poly-ethylene-
glycol 4000 (GIBCO-BRL, Life Technologies, Inc., Grand Island, NY).
The fused cells were plated onto 96-well plates and cultured in Optimum
medium. The standard hypoxanthine-aminopterin-thymidine (HAT) se-
lection procedure was applied to select the hybridoma clones (Harlow and
Lane, 1988). The media from wells with growing cells were tested by
Western blot analysis against 
 
C
 
.
 
 tentans
 
 RNP extracts. To select antibodies
binding to Balbiani rings, the media were also tested by immunostaining of
polytene chromosome squashes (Visa et al., 1996
 
b
 
). Cells from the positive
wells were cloned at least three times by limiting dilution. The mAb 1D3,
which recognized a 23-kD protein and bound to BRs, was chosen for fur-
ther analysis.
 
SDS-PAGE and Western Blot Analysis
 
The proteins in the RNP extract were precipitated with cold acetone, re-
suspended in sample buffer (10% glycerol, 2% SDS, 10 mM DTT, 0.02%
bromophenol blue, and 0.0625 M Tris-HCl, pH 6.8), and separated by
electrophoresis in a 10% polyacrylamide gel containing 0.1% SDS. After
electrophoresis, the proteins were blotted to transfer membranes (Immo-
bilon-P; Millipore Corp., Bedford, MA) using a Trans-Blot semidry elec-
trophoretic system (Bio-Rad Laboratories, Hercules, CA). Membranes
were blocked in PBS containing 10% dry milk powder for 1 h and incu-
bated with primary antibodies diluted in PBS containing 1% dry milk
powder and 0.05% Tween-20. Labeling was visualized with alkaline phos-
phatase–conjugated anti–mouse immunoglobulin (DAKO A/S, Glostrup,
Denmark) using the NBT/BCIP system (Promega Corp., Madison, WI).
 
Immunostaining of Polytene Chromosomes
 
Salivary glands were isolated from fourth instar larvae and prefixed for 90 s
at room temperature in 2% paraformaldehyde in TKM (100 mM KCl, 1 mM
MgCl
 
2
 
, and 10 mM triethanolamine-HCl, pH 7.0). The prefixed glands
were washed in cold TKM for 5 min, kept for 60 s in TKM buffer contain-
ing 2% NP-40, and transferred into 0.025% NP-40 in TKM. The subse-
quent isolation of the polytene chromosomes was performed on a cold
stage close to 0
 
8
 
C. Under a stereomicroscope, the glands were repeatedly
sucked in and out of a micropipette with a narrow opening (bore diameter
250 
 
m
 
m) to release polytene chromosomes. Single chromosomes were
identified and transferred with a pipette into a drop of TKM placed on a
siliconized glass slide (for details see Björkroth et al., 1988). The NP-40–
containing solution was exchanged with fresh TKM to get the chromo-
somes to stick to the surface of the glass slide. The isolated polytene chro- 
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mosomes were postfixed with 4% paraformaldehyde in TKM for 30 min
at room temperature and washed three times with fresh TKM. Subse-
quently, they were used immediately for the immunocytological analysis.
For preparation of RNase-treated chromosomes, the isolated polytene
chromosomes were incubated with 100 
 
m
 
g/ml of RNase A in TKM buffer
for 60 min at room temperature immediately after isolation. The RNase
A–treated chromosomes were then rinsed in TKM, postfixed, and incu-
bated with primary and secondary antibodies as described above.
For immunocytological analysis, the isolated chromosomes were
blocked with 50 
 
m
 
l of 2% BSA in TKM for 30 min at room temperature in
a humid chamber and incubated for 45 min with 40 
 
m
 
l of undiluted 1D3
hybridoma supernatant or 40 
 
m
 
l of the negative control mouse mono-
clonal anti–factor VIII antibody (DAKO A/S) diluted 1:50 in TKM. The
slides were washed three times for 5 min in 0.1% Tween-20 in TKM and
incubated for 90 min with 50 
 
m
 
l of the gold-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA; IgG, 6 nm in di-
ameter) diluted 1:50 in TKM containing 0.5% BSA. The specimens were
washed three times for 5 min in TKM and with distilled water, an immu-
nogold silver enhancement solution (IntenSEM; Amersham Corp., Buck-
inghamshire, England) was added onto the specimens for 8–10 min at
room temperature, and the specimens were rinsed in distilled water,
mounted in 30% glycerol, and examined and photographed in a light mi-
croscope (Carl Zeiss, Inc., Thornwood, NY).
 
Isolation of 1D3-specific cDNA Clones
 
The hybridoma culture supernatant containing mAb 1D3 was diluted
1:100 to screen a randomly primed 
 
l
 
gt11 
 
C
 
.
 
 tentans
 
 salivary gland cDNA
library by the ProtoBlot Immunoscreening System (Promega Corp.). Two
antibody-specific clones were purified and sequenced. One of them,
pHRP23.1, was used as template for PCR amplification with 
 
l
 
gt11 for-
ward and reverse primers (Promega Corp.). The amplified DNA fragment
was purified by the Wizard™ PCR Preps DNA Purification Kit and la-
beled by the DIG DNA Labeling and Detection Kit (Boehringer Mann-
heim GmbH, Mannheim, Germany). The labeled probe was used to
screen an oligo dT–primed 
 
l
 
ZAP cDNA library from the salivary glands
of 
 
C
 
.
 
 tentans 
 
following the manufacturer’s instructions. 10 positive clones
were obtained and purified for sequence analysis.
 
DNA Sequencing and Sequence Analysis
 
The cDNA inserts of positive clones were amplified by PCR. The purified
DNA fragments were used for sequencing with walking primers. The Taq
DyeDeoxy™ Terminator Cycle Sequencing Kit (PE Applied Biosystems,
Warrington, GB) was applied for the sequence reaction and sequencing
gel was run on an automated DNA sequencer (model 373A; PE Applied
Biosystems). The DNA sequences were analyzed with the University of
Wisconsin Genetics Computer Group Sequence Analysis Programs (De-
vereux et al., 1984) and EGCG extensions to the Wisconsin Package Se-
quence Analysis Programs.
 
Expression of hrp23 and Identification of
Expression Product
 
The hrp23 protein was expressed according to the Promega protocol for
expression of lambda lysogen in preparative amounts. The 
 
E
 
.
 
 coli
 
 Y1089
were infected with a 
 
l
 
gt11 clone, pHRP23.1, containing hrp23 cDNA, and
the presence of the hrp23 sequence insert was confirmed by PCR using in-
ner primers. Half of the bacterial culture was IPTG-induced, while the
other half served as control. Both cultures were lysed in 2
 
3
 
 sample buffer
at 95
 
8
 
C for 5 min, and the supernatants were analyzed with SDS-PAGE
and Western blotting as described above with a few modifications. The
electrophoresis was performed in 12% polyacrylamide gels. The 1D3 hy-
bridoma supernatant was diluted 1:100. The membrane was subjected to
ECL (Amersham Corp.) according to the manufacturer’s instructions us-
ing a peroxidase-conjugated goat anti–mouse immunoglobulin (DAKO
A/S) diluted 1:500 in PBS provided with 0.1% Tween.
 
Alkaline Phosphatase Treatment of RNP Extract
 
The RNP extract was divided into two equal portions: one was treated
with 250 U/ml of calf intestine alkaline phosphatase (Boehringer Mann-
heim GmbH) for 30 min at 37
 
8
 
C and the other in parallel with no enzyme
added but with 5 mM 
 
b
 
-glycerophosphate. The protein was precipitated
with acetone and resuspended for SDS-PAGE as described above.
 
Immunocytology on Cryosections
 
Immunostaining on semithin cryosections of tissue culture cells and sali-
vary glands was performed as previously described (Visa et al., 1996
 
a
 
).
When 
 
C
 
.
 
 tentans
 
 tissue culture cells were used, the cells were washed once
in PBS and collected as a pellet. The cell pellet and salivary
 
 
 
glands were
fixed for 45–60 min in 4% formaldehyde in 0.1 M cacodylate buffer, pH
7.2, at room temperature. The fixed pellet and salivary glands were cryo-
protected with 2.3 M sucrose and frozen by immersion in liquid nitrogen.
Semithin sections (0.5 
 
m
 
m) were obtained in a cryo-ultramicrotome (Ul-
tracut S/FC S; Reichert-Jung, Vienna, Austria) and mounted on glass
slides. Before immunolabeling, the sections were incubated in PBS con-
taining 0.1 M glycine and 2% BSA. As first antibody, we used either undi-
luted 1D3-hybridoma supernatant or 20 
 
m
 
g/ml anti–factor VIII antibody
(negative control). In the second step of the immunostaining, we used an
antibody against mouse IgG conjugated to 6-nm gold particles (Amer-
sham Corp.). The immunogold labeling was silver-enhanced with
IntenSE™ M (Amersham Corp.).
 
Immunoelectron Microscopy
 
Immunoelectron microscopy was essentially carried out according to the
method described by Tokuyasu (1980) with a few modifications (Visa et al.,
1996
 
a
 
). The specimens were prepared as described above for light micros-
copy except that fixation was performed for 20–25 min in 4% formalde-
hyde and 0.1% glutaraldehyde. Ultrathin cryosections were picked up on
drops of 2.3 M sucrose and deposited on nickel grids coated with formvar
and carbon. The grids were floated on drops of PBS containing 10% new
born calf serum before incubation with the antibody solutions. The same
antibodies as described above under “Immunocytology on Cryosections”
were used. After immunolabeling, the sections were stained with 2%
aqueous uranyl acetate and embedded in 4% polyvinyl alcohol (9–10 kD;
Aldrich Chemical Co., Milwaukee, WI). The specimens were examined
and photographed in a microscope (model 100 CX; JEOL U.S.A., Pea-
body, MA) at 80 kV.
 
Results
 
Generation and Selection of a Monoclonal Antibody 
against a 23-kD hnRNP Protein in C. tentans
 
Monoclonal antibodies were raised against hnRNP pro-
teins immunoprecipitated from a
 
 C
 
. 
 
tentans
 
 nuclear RNP
extract. 
 
C
 
.
 
 tentans
 
 tissue culture cells were homogenized,
and the intact nuclei were collected and used for prepara-
tion of the RNP extract as described by Wurtz et al.
(1996). The RNP extract contained a large number of pro-
teins as shown by SDS-PAGE (Fig. 1 
 
a
 
, lane 
 
1
 
). The
hnRNP complexes were immunoprecipitated from the
RNP extract by a two-step procedure, using a monoclonal
antibody against hnRNP protein hrp36 (mAb 4F9) and an
anti–mouse immunoglobulin coupled to protein A–Seph-
arose. The bound proteins were eluted, precipitated, and
subjected to SDS-PAGE (Fig. 1 
 
a
 
, lane 
 
2
 
). The immuno-
precipitation resulted in a less complex protein pattern
suitable for production of monoclonal antibodies.
The immunoprecipitated proteins were used to immu-
nize BALB/c mice according to the standard procedure.
Several major proteins in the nuclear extract reacted with
mouse sera in Western blots (Fig. 1 
 
b
 
, lane 
 
1
 
). The spleen
cells of the immunized mouse were fused with mouse my-
eloma Sp20 cells, and hybridoma clones were selected with
a standard hypoxanthine-aminopterin-thymidine (HAT)
procedure. Positive clones were identified by screening hy-
bridoma supernatants against the 
 
C
 
.
 
 tentans
 
 RNP extract
in Western blot experiments (Wurtz et al., 1996). The su-
pernatant of one hybridoma clone, 1D3, showed high af-
finity for a 23-kD protein in the 
 
C
 
.
 
 tentans
 
 nuclear RNP 
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extract (Fig. 1 
 
b
 
, lane 
 
2
 
); the same result was obtained with
a 
 
C
 
.
 
 tentans
 
 cytoplasmic extract (data not shown). No
bands were detected in the control lane with the anti–fac-
tor VIII antibody (Fig. 1 
 
b
 
, lane 
 
3
 
). Furthermore, in pre-
liminary chromosome squash experiments, the 1D3 anti-
body reacted with the BRs (data not shown). On the basis
of these experiments, we selected the 1D3 clone for fur-
ther experiments and designated the corresponding 23-kD
protein Ct-hrp23 (or hrp23, for short), following earlier es-
tablished nomenclature for hnRNP proteins in 
 
Diptera
 
(Matunis et al., 1992; Wurtz et al., 1996).
 
hrp23 Is Present in BRs, Other Chromosomal Puffs, 
and in Nucleoli
 
To determine the chromosomal distribution of hrp23, we
performed immunolabeling experiments on isolated poly-
tene chromosomes. The chromosomes were isolated from
prefixed salivary glands, immunolabeled with mAb 1D3
(or anti–factor VIII antibody as control), visualized by a
gold-conjugated secondary antibody, and silver enhanced.
The 1D3 antibody reacted strongly with the large BRs on
chromosome IV (Fig. 2 
 
a
 
). However, smaller puffs were
also immunostained as seen both on chromosome IV (Fig.
2 
 
a
 
) and chromosome III (Fig. 2 
 
c
 
). In addition, it was
noted that nucleoli stained with 1D3 (Fig. 2 
 
c
 
). The stain-
ing of BRs, minor puffs, and nucleoli was sensitive to
RNase (not shown). The negative control did not exhibit
any significant staining (Fig. 2, 
 
b
 
 and 
 
d
 
). In conclusion, the
hrp23 protein is likely to be present in BRs, a large num-
ber of additional, smaller chromosomal puffs, and in the
two nucleoli. As the immunostaining is sensitive to RNase,
it is suggested that hrp23 is a protein associated with RNA.
 
cDNA Cloning of hrp23
 
By screening cDNA libraries prepared from 
 
C
 
.
 
 tentans
 
 sal-
ivary glands, the full cDNA sequence for hrp23 was found.
First, the 1D3 antibody was used to screen a randomly
primed 
 
l
 
gt11 cDNA library made from salivary glands of
 
C
 
.
 
 tentans
 
. Two antibody-specific clones were isolated and
sequenced. One of the clones, pHRP23.1, was used to syn-
Figure 1. Generation and characterization of monoclonal anti-
body 1D3. (a) SDS-PAGE of the proteins in the RNP extract
from C. tentans tissue culture cells (lane 1), and of the proteins
immunoprecipitated from the RNP extract by mAb 4F9 and used
for subsequent immunization of BALB/c mice (lane 2). The pro-
tein recognized by mAb 4F9, hrp36, is indicated with an asterisk
at lane 2. The position of molecular mass standards is shown to
the left in kilodaltons. (b) Western blot analysis of the RNP ex-
tract probed with serum from an immunized mouse (lane 1 ),
mAb 1D3 (lane 2), and negative control antibody (lane 3). The
molecular mass standards are the same as in a.
Figure 2. Immunolocalization of hrp23 on isolated C. tentans
polytene chromosomes. The chromosomes were isolated from
prefixed salivary glands and incubated with monoclonal antibody
1D3 (a and c) or with an anti–factor VIII antibody as negative
control (b and d). The antibody-binding sites were visualized by a
gold-conjugated secondary antibody and silver enhancement. Ex-
amples of chromosome IVs (a and b) and chromosomes IIIs (c
and d) are shown. The positions of BR1, BR2, and nucleolus
(Nu) have been indicated. Bar, 10 mm.
 The Journal of Cell Biology, Volume 142, 1998 1186
thesize a DNA probe by PCR amplification. The probe
was labeled with digoxigenin and used to screen an
oligo(dT)-primed lZAP cDNA library made from sali-
vary glands. 10 positive clones were found and sequenced
(see below). All clones had the same coding sequence; no
variant was found in spite of extensive screening of the sal-
ivary gland cDNA libraries.
To demonstrate that the protein, encoded in the cDNA
clone, is indeed recognized by 1D3 in the RNP extract, a
crude lysate containing the hrp23 recombinant protein was
prepared by expressing the desired l lysogen in Escher-
ichia coli. The expressed protein was then compared with
the native hrp23 protein extract by Western blot analysis
using the 1D3 antibody and the ECL detection system. In
the extract from the induced bacteria, the 1D3 antibody
recognized a prominent protein fraction corresponding to
an apparent molecular mass of 23 kD (Fig. 3, lane 4). A
very weak band at the same position was seen in the non-
induced bacteria, probably because of leaky expression of
the lysogen (Fig. 3, lane 3). The recombinant protein mi-
grated somewhat more rapidly than hrp23 in the RNP ex-
tract from C. tentans tissue culture cells (Fig. 3, lane 1).
When the RNP extract was treated with alkaline phos-
phatase, this discrepancy disappeared (Fig. 3, lane 2). We
conclude that the recombinant protein reacts with the 1D3
antibody and has the expected apparent molecular mass of
hrp23. In addition, it is inferred that the native hrp23 pro-
tein is likely to be phosphorylated, which has been further
supported by phosphate labeling experiments in vivo (Ais-
souni, Y., and B. Daneholt, unpublished results).
The cDNA Sequence of hrp23
The hrp23 protein contains 191 amino acids, and the pre-
dicted molecular mass is 20 kD, which is somewhat smaller
than the apparent molecular mass in SDS-PAGE (23 kD).
hrp23 has a modular structure like other hnRNP proteins:
there is an NH2-terminal RNA-binding domain contain-
ing the RNP-1 and RNP-2 consensus sequences, and a
COOH-terminal auxiliary domain rich in glycine (37%),
arginine (21%), and serine (16%) (Fig. 4). It should be
noted that the auxiliary domain contains clustered gly-
cines, three Arg-Gly-Gly (RGG) tripeptides, and eight
Arg-Ser or Ser-Arg dipeptides.
The hrp23 protein was compared with other RNA-bind-
ing proteins using the EMBL data base (Rice et al., 1993)
and the Swiss-PROT data base (Bairoch and Boeckmann,
1993). A Drosophila protein, ROX21 (Brand et al., 1995),
proved to be very similar to hrp23; the amino acid identity
between the two proteins amounts to 74% in the RBD do-
main and to 48% in the auxiliary domain (Fig. 5). Further-
more, hrp23 (and ROX21) shares major features with sev-
eral RNA-binding proteins in mammals, insects, and
plants, which contain one or two NH2-terminal RBDs and
a COOH-terminal auxiliary domain.
The glycine-rich auxiliary domain of hrp23 prompted
comparisons between hrp23 and a subgroup of hnRNP
proteins, the RBD-Gly RNA-binding proteins. These pro-
teins contain one or two NH2-terminal RBDs and a gly-
cine-rich COOH-terminal domain (for reviews see Birney
et al. 1993; Dreyfuss et al., 1993). The RBD-Gly proteins
with one RBD comprise RBM3 (Derry et al., 1995) and
hnRNP G (Soulard et al., 1993) in human and a series of
exceptionally Gly-rich proteins in plants (for references
see Bergeron et al., 1993; van Nocker and Vierstra, 1993).
The RBD-Gly proteins with two RBDs include hnRNP
A1 (Buvoli et al., 1988) and hnRNP A2/B1 (Burd et al.,
1989) in human, hrp 36/38, hrp40, and hrp48 in Drosophila
(Haynes et al., 1990, 1991; Matunis et al., 1992), and hrp36
in  Chironomus (Visa et al., 1996a). The hrp23 and the
RBD-Gly proteins all have a typical RBD with the RNP-1
and RNP-2 submotifs, and the amino acid sequence iden-
tity between the RBD of hrp23 and that of the others is in
the range of 21–37%. The auxiliary domains of hrp23 and
the RBD-Gly proteins display the same basic structure:
clustered glycine residues being interspersed with arginine
and aromatic amino acids. The sequence RGG (GRG or
GGR) is also a characteristic feature. In hrp23, the aro-
matic amino acid is phenylalanine, while in most of the
others it is tyrosine. The auxiliary domain of hrp23 shows a
sequence identity of 25–39% with that of the other non-
plant proteins and as high as 41–45% with the exception-
ally glycine-rich (z70%) auxiliary domains of the plant
proteins. However, it should be recalled that it is difficult
to compare glycine-rich domains with each other because
of the very low sequence complexity (Birney et al., 1993).
We conclude that hrp23 has features in common with the
RBD-Gly proteins: the RBD is similar, and the auxiliary
domain is glycine-rich with RGG repeats and interspersed
aromatic acids.
The presence of several RS/SR dipeptides in the auxil-
iary domain of hrp23 necessitated comparisons between
hrp23 and the SR protein family, the members of which
contain one or more RBDs and an auxiliary RS domain. In
SR proteins, the RS domain is characterized by a large
number of RS/SR dipeptides, often in clustered arrange-
ments. The following three SR proteins, all with one RBD
and a molecular mass of z20 kD, showed the strongest
similarities to hrp23: SRp20 (Ayane et al., 1991; Zahler et al.,
1992) and 9G8 (Cavaloc et al., 1994) from human and
RBP1 from Drosophila (Kim et al., 1992). The RBD re-
gion of hrp23 is 46, 49, and 41% identical to the RBD re-
gion of SRp20, 9G8, and RBP1, respectively; the RNP-1
and RNP-2 submotifs are perfectly conserved in the four
proteins. Furthermore, when comparisons were made be-
tween the corresponding auxiliary domains, the following
figures were obtained: 29, 25, and 41% sequence identity,
respectively. The SR/RS dipeptides are, however, fewer
(8) in hrp23 than in the three small SR proteins (12–31),
Figure 3. Western blot com-
parison of hrp23 from C. ten-
tans tissue culture cells with
hrp23 expressed in E. coli.
The extracted proteins were
separated by SDS-PAGE,
blotted onto transfer mem-
branes, and probed with mAb
1D3. Lane 1 , RNP extract
from tissue culture cells. Lane
2, alkaline phosphatase–treated RNP extract from tissue culture
cells. Lane 3 , extract from E. coli, containing the hrp23 cDNA
clone, before IPTG induction. Lane 4, extract from E. coli, con-
taining the hrp23 cDNA clone, after IPTG induction. The posi-
tions of two molecular mass standards are indicated to the left.Sun et al. Behavior of an hnRNP Protein during RNP Export 1187
and the dipeptides in hrp23 are interspersed rather than
clustered. Furthermore, the monoclonal antibody mAb104,
which is known to recognize a phosphoepitope in the RS
domain of SR proteins (Roth et al., 1991), does not react
with hrp23 (data not shown). We conclude that hrp23 re-
sembles the SR proteins, as its RBD is strikingly similar to
that of the SR proteins and its auxiliary domain of hrp23
contains several SR/RS dipeptides, but it is also evident
that hrp23 does not fulfill all the criteria for a typical SR
protein.
In summary, hrp23 is an RNA-binding protein with a
single NH2-terminal RBD and a COOH-terminal auxiliary
domain rich in glycine, arginine, and serine. The hrp23 has
a homologous counterpart in the Drosophila protein
ROX21, and it shares important features with both RBD-
Gly proteins and SR proteins (see Discussion).
hrp23 Is Mainly Located in the Nucleus
To reveal the intracellular distribution of hrp23, the salivary
glands were studied with immunocytology. Semithin sec-
tions of salivary glands were incubated with the 1D3 anti-
body and subsequently with a gold-conjugated secondary
antibody. The labeling was examined after silver enhance-
ment. The nuclei of the salivary glands were heavily immu-
nostained (Fig. 6, a and b). Puffs and nucleoli (cf., Fig. 2)
were decorated by the antibody as well as the nucleoplasm
surrounding the polytene chromosomes. The cytoplasm was
weakly stained (Fig. 6, a and b). In the control (Fig. 6 c), no
immunostaining could be detected either in the nucleus or in
the cytoplasm; the negative control is also shown in phase
contrast (Fig. 6 c9). We conclude that hrp23 is mainly located
in the nucleus and that hrp23 is present both on the polytene
chromosomes and in the surrounding nucleoplasm.
hrp23 Is Present in Growing and in Nucleoplasmic
BR RNP Particles but Is Absent from the BR Particles 
Bound to the Nuclear Pore Complex
Immunoelectron microscopy was used to investigate the
behavior of hrp23 in relation to the assembly and trans-
port of BR pre-mRNP particles. Salivary glands were fixed
and frozen, and ultrathin cryosections were prepared. The
sections were incubated with antibodies, stained with
Figure 4. Nucleotide sequence
and deduced amino acid se-
quence of the hrp23 cDNA
clone pHRP23.2. This HRP
clone was the longest one re-
corded and sequenced. The
RBD is boxed. Within RBD,
the two most highly conserved
sequence elements, RNP-1
(solid line) and RNP-2 (dashed
line) are underlined. The end
of the coding region is indi-
cated by an asterisk. These
sequence data are available
from the EMBL DNA data
base under accession number
AJ003820.
Figure 5. Primary structure
comparison of hrp23 with
Drosophila Rox21 protein.
The two complete amino acid
sequences are aligned and
presented by the PILEUP
and PRETTYPLOT pro-
grams. Regions with sequence
similarity are boxed. Gaps in
the alignment are shown by
dashes.The Journal of Cell Biology, Volume 142, 1998 1188
aqueous uranyl acetate, and embedded in polyvinyl alco-
hol. The specimens were examined and photographed in a
transmission electron microscope.
The immunoelectron microscopy analysis was focused
on the giant puffs, the BRs. The active genes appear as
chromosomal loops, along which the growing BR RNP
particles can be analyzed. In a single section, examples of
promoter-proximal (p), middle (m), and promoter-distal
(d) portions of the BR genes can be discerned (Fig. 7 a). In
the proximal region, the RNP products appear as short
thick fibers, while further downstream the gene, they can
be described as stalked granules. This conformational
change is due to the fact that the RNP fiber is being
packed into a globular structure, which gradually increases
in diameter along the course of transcription (for more de-
tailed description see Kiseleva et al., 1994).
As shown in Fig. 7 a, growing RNP particles in all three
segments of the BR gene are labeled with gold (cf., the
complete absence of gold particles in the control in Fig. 7
f). Thus, the hrp23 protein is being added to the BR tran-
script concomitant with transcription. The BR RNP parti-
cles can be seen released into the nucleoplasm (Fig. 7 b),
and when they pass through the nuclear pore after having
changed from a globular to a more extended conformation
(Fig. 7, c and d). Beneath the electron micrographs of the
nucleoplasmic and translocating particles, we have out-
lined the particles in schematic drawings, where also the
nuclear envelope is indicated (Fig. 7, b9–d9). Most of the
nucleoplasmic particles are decorated by gold (Fig. 7, b–d,
arrows), while no gold is seen associated with the translo-
cating particles. To further substantiate this point, we car-
ried out a semiquantitative analysis. 400 nucleoplasmic
particles were scrutinized, and 62% of them were labeled
(242/400). We recorded 17 well-defined translocating par-
ticles, none of them labeled. Thus, hrp23 seems to be
present in the nucleoplasmic particles, also in those close
to the nuclear envelope, but once the BR particles become
attached to the nuclear pore complex and translocate
through the pore, the hrp23 protein is absent. In conclu-
sion, the hrp23 protein is bound to the BR RNA concomi-
tant with transcription, remains bound to the released BR
RNA particles in the nucleoplasm, but is released from the
particle before or at the binding of the particle to the nu-
clear pore complex for further exit into the cytoplasm.
The hnRNP particles present in chromosomal puffs other
than the BRs are also decorated with gold (data not shown)
(cf., the immunostaining of smaller puffs in Fig. 2, a and c).
When released into the nucleoplasm, they often appear in a
more or less fibrous conformation and can be seen immuno-
labeled (Fig. 7 c). Therefore, hrp23 seems also to associate
with non–BR hnRNA during transcription, and it presum-
ably stays with the RNA after its release into the nucleo-
plasm. Whether hrp23 is shed before the nucleocytoplasmic
transport of the RNA cannot be decided in this case, as the
non-BR hnRNP complexes cannot be recognized as well-
defined entities when passing through the nuclear pores.
In the cytoplasm, the density of labeling was low, but it
was significantly higher than in the negative control (Fig.
7, e vs. f). The gold particles were seen scattered in the cy-
toplasm between or close to the tubules of the endoplas-
mic reticulum (Fig. 7 e). Thus, a small amount of hrp23 can
be detected in the cytoplasm. One possible interpretation
would be that the low level of labeling corresponds to na-
scent and newly synthesized hrp23, but other explanations
are conceivable (see further Discussion).
hrp23 Is Present in the Nucleolus
The analysis of immunolabeled polytene chromosomes re-
vealed that hrp23 is present in the nucleoli of salivary
gland cells. This result was confirmed and extended with
immunoelectron microscopy. Fig. 8 a shows a segment of a
nucleolus with its fibrillar (F) and granular (G) regions in-
dicated. A small region (square) is presented at a higher
magnification in Fig. 8 b. Gold particles appeared in both
the fibrillar and granular compartments (Fig. 8 b, arrows),
while no labeling could be visualized in the negative con-
Figure 6. Immunocytological localization of hrp23 in C. tentans
salivary gland cells. Semithin cryosections of salivary glands were
treated with mAb 1D3 (or with a negative control antibody), a
gold-conjugated secondary antibody was added, and the antibody
binding was visualized by silver enhancement. The 1D3-treated
specimens are shown in bright field (a and b), and the negative
controls are shown in bright field (c) and phase contrast (c9). The
nuclei (NUC), cytoplasm (CYT), and gland lumen (LUM) are in-
dicated. Bars, 40 mm.
Figure 7. Immunoelectron microscopic localization of hrp23 in C. tentans salivary gland cells. Thin cryosections were incubated with
mAb 1D3 (a–e), or with a negative control antibody (f), and a gold-conjugated secondary antibody was used to visualize the labeled
sites. (a) Proximal (p), middle (m), and distal (d) segments of transcriptionally active BR genes. (b–d) Nucleoplasmic BR particles close
to the nuclear envelope (arrows) and extended BR particles translocating through the nuclear pores. Schematic interpretations of the
electron micrographs are shown beneath (b9–d9). The nucleus (N) is located above the nuclear envelope, and cytoplasm (C) is located
beneath. The non–BR hnRNP complexes appear in the nucleoplasm as an irregular fibrous network labeled with a few gold particles
(c). (e) Cytoplasm containing tubular ER with associated ribosomes. The arrows point at gold particles. (f) The negative control show-
ing nuclear envelope with adjacent nuclear (N) and cytoplasmic (C) regions. In the nucleus, growing BR RNP particles can be discerned
(cf., a). Bar, 100 nm.Sun et al. Behavior of an hnRNP Protein during RNP Export 1189The Journal of Cell Biology, Volume 142, 1998 1190
trol (Fig. 8 c). As the labeling of nucleoli is RNase sensi-
tive, we conclude that hrp23 is probably associated with
RNA in the nucleolus, but the nature of this RNA remains
to be determined.
hrp23 Is Likely to be a Nonshuttling Protein
To analyze whether hrp23 behaves as a shuttling protein in
C. tentans, we performed an actinomycin D experiment as
devised by Pinol-Roma and Dreyfuss (1991). In this type
of experiment shuttling, but not nonshuttling, proteins will
accumulate in the cytoplasm. C. tentans tissue culture cells
were incubated for 1 h with actinomycin D in the presence
of cycloheximide, fixed, sectioned, and challenged with an-
tibodies; untreated cells were analyzed in parallel. The
hrp36 protein served as control representing the behavior
of a shuttling protein. The hrp23 protein was recorded
mainly in the nucleus in both treated and untreated cells
(Fig. 9). Thus, no accumulation of hrp23 in the cytoplasm
was detected. In the control, the shuttling protein hrp36
shifted from the nucleus to the cytoplasm during the drug
experiment (Fig. 9). This result shows that hrp23 is not a
transcription-dependent shuttling hnRNP protein and in-
dicates that it is a nonshuttling protein. This is in good
agreement with the observation that hrp23 is shed from
the BR particles before the translocation of the particles
through the nuclear pores.
Discussion
Functional Implications of the Structure of the hnRNP 
Protein hrp23
The hrp23 protein contains a single NH2-terminal RNA-
binding domain and a COOH-terminal domain rich in gly-
Figure 8. Immunoelectron microscopic localization of hrp23 in the
nucleolus of C. tentans salivary glands. Semithin sections through
a nucleolus in a salivary gland cell were treated with mAb 1D3,
and the binding was visualized by a gold-conjugated secondary
antibody. In parallel, sections were incubated with a negative
control antibody. (a) A segment of a nucleolus, with its fibrillar
(F) and granular (G) compartments, and the surrounding nucleo-
plasm (NP). (b) The area demarcated with a rectangle in a, at
higher magnification. The arrows denote the position of gold par-
ticles. (c) The negative control. Bars: (a) 250 nm; (b and c) 100 nm.
Figure 9. Transcription-independent nuclear localization of hrp23.
C. tentans tissue culture cells were treated for 1 h with (act D) or
without (normal) actinomycin D in the presence of cycloheximide.
To locate hrp23, semithin cryosections were incubated with mAb
1D3 and subsequently with a gold-conjugated secondary antibody.
The labeling was visualized by silver enhancement and photo-
graphed in bright field. The distribution of the shuttling protein
hrp36 was analyzed in parallel with mAb 4F9. Some of the immu-
nopositive nuclei have been indicated by arrows. Bar, 25 mm.Sun et al. Behavior of an hnRNP Protein during RNP Export 1191
cine, arginine, and serine. There is a recently described ho-
mologue in Drosophila, the ROX21 protein (Brand et al.,
1995). Furthermore, sequence comparisons with RNA-
binding proteins revealed that hrp23 is similar to the
RBD-Gly proteins as well as to the SR proteins, all exhib-
iting one or two NH2-terminal RBDs and an auxiliary do-
main. In particular, the presence of clustered glycine resi-
dues, RGG repeats, and an interspersed aromatic amino
acid (phenyalanine) in the auxiliary domain makes hrp23
appear similar to the RBD-Gly RNA-binding proteins
with their glycine-rich auxiliary domain. However, the
RBD in hrp23 shows a strikingly high (z45%) identity to
the RBD of low molecular weight SR proteins, and the
auxiliary domain in hrp23 contains several SR/RS dipep-
tides. It seems, therefore, as if hrp23 and its Drosophila
homologue ROX21 represent a group of proteins interme-
diate in structure between the RBD-Gly proteins and the
SR proteins, which suggests that there is not a sharp
boundary between these two groups of hnRNP proteins.
RGG-rich domains are present in a large number of
proteins involved in various aspects of RNA metabolism,
such as pre-rRNA processing, pre-mRNA splicing, and
RNA helicase activity (for references see Steinert et al.,
1991; Kiledjian and Dreyfuss, 1992). It is interesting to
note that in hnRNP U protein, which lacks an RBD, a sin-
gle COOH-terminal RGG-rich region, termed the RGG
box, is known to be sufficient for RNA binding (Kiledjian
and Dreyfuss, 1992). Likewise, a COOH-terminal frag-
ment of nucleolin, containing an RGG-box like domain, is
also able to independently accomplish binding to RNA
(Ghisolfi et al., 1990). Furthermore, in hnRNP A1, the
RGG-rich domain acts in a cooperative manner as to
RNA binding with the two RBDs (Kumar et al., 1990). It
is therefore possible that the RGG-containing auxiliary
domain in hrp23 also promotes binding of the protein to
the pre-mRNA molecule and perhaps also affects the
specificity of the binding to the RNA.
The SR proteins are known to act as splicing factors in
both in vitro and in vivo experiments (for review see Fu,
1995). For all three SR proteins most closely related to
hrp23, it has been demonstrated that they can function as
splicing factors. The RBP1 protein in Drosophila can both
activate splicing and switch splice site selection in in vitro
experiments (Kim et al., 1992). The human 9G8 protein is
an essential splicing factor as also shown in experiments in
vitro (Cavaloc et al., 1994). Finally, Screaton et al. (1995)
could demonstrate in vivo that the human SRp20 protein
can regulate alternative splicing. Thus, it seems as if this
group of SR proteins is essential for splicing and can mod-
ulate alternative splicing, but it remains to be proven
whether also hrp23 acts as a splicing factor.
hrp23 and Transport of BR RNP Particles
The hrp23 protein is added to BR pre-mRNA concomi-
tant with transcription. It is present in the proximal, mid-
dle, and distal regions of the active gene. The protein is,
therefore, added early during the transcription process,
and most likely also along the entire BR transcript like the
other two hnRNP proteins earlier studied, hrp36 (Kiseleva
et al., 1994) and hrp45 (Alzhanova-Ericsson et al., 1996). It
should be noted that concomitant with transcription, splice-
osomes rapidly assemble and disassemble on the 59 region
of the transcript and start to assemble at the 39 end of the
transcript, leaving the middle section of the gene devoid of
spliceosome components (Kiseleva et al., 1994). As hrp23
remains bound to the growing RNP particles all during
transcription, hrp23 is not likely to be a true spliceosomal
component. This is further supported by the observation
that hrp23 is present in the released nucleoplasmic BR
particles, the vast majority of which contain fully spliced
BR RNA and no spliceosome components like snRNP.
These results do not rule out the possibility that hrp23 is
involved in splicing. However, if so, hrp23 (like the SR
protein hrp45) should exert its action as a structural com-
ponent of the elementary RNP fiber in the BR particles.
The nucleoplasmic BR particles are frequently labeled
in the immunoelectron microscopy experiment; more than
half of them are decorated with gold. This is a high figure
considering that all particles are not likely to be accessible
to the antibodies in the sections because of steric hin-
drance. It is then a striking observation that no BR parti-
cles have been seen immunolabeled when bound to the
nuclear pore complex or when translocating through the
central channel of the complex. Evidently, hrp23 is re-
leased from the BR particle just before the binding of the
particle to the pore complex or in conjunction with the
binding. It can be speculated that the shedding of hrp23
could even be a prerequisite for binding. It should be
noted that this behavior of hrp23 is different from that of
the SR protein hrp45. This protein is present on the parti-
cle at the pore (translocating particles are immunolabeled
to almost the same extent as nucleoplasmic particles), but
it is discarded when the RNP particle changes conforma-
tion and is entering the central channel, indicating that this
SR protein could be linked to the translocation per se
(Alzhanova-Ericsson et al., 1996).
The hrp23 protein does not seem to leave the nucleus and
should therefore be classified as a nonshuttling protein. This
was further substantiated in the present study by an actino-
mycin D experiment performed with C. tentans tissue cul-
ture cells according to Pinol-Roma and Dreyfuss (1991). It
was not possible to translocate the nuclear hrp23 into cyto-
plasm during the drug treatment, while the shuttling protein
hrp36 analyzed in parallel accumulated in the cytoplasm.
This result suggested that not only is the hrp23 bound to BR
RNP particles confined to the nucleus, but so is the hrp23 in
all hnRNP particles. It should, however, be recalled that a
shuttling experiment could be misleading because some
hnRNP proteins, e.g., Npl3 in yeast (Lee et al., 1996), only
shuttle in the presence of on-going transcription.
A small amount of hrp23 was detected in the cytoplasm
in the immunocytology and in the immunoelectron mi-
croscopy experiments. The explanation closest at hand is
that the low immunosignal corresponds to nascent and
newly synthesized hrp23. However, considering the small
size of hrp23, it is also possible that free hrp23 can diffuse
through the nuclear pore and appear in the cytoplasm;
proteins below 40–60 kD are able to do so (Peters, 1986).
Finally, we cannot exclude, although we regard it as less
likely, that a low amount of hrp23 is transported from the
nucleus to the cytoplasm as part of an RNP complex origi-
nating from one or more of the smaller chromosomal puffs
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When the behavior of hrp23 is considered in relation to
the total information available on the transport of BR par-
ticles in the salivary gland cells, a dynamic picture
emerges. Until now, the following components have been
studied during the assembly and transport of the BR parti-
cles: snRNP proteins (Kiseleva et al., 1994), the cap-bind-
ing protein CBP20 (Visa et al., 1996b), hrp36 (Visa et al.,
1996a), hrp45 (Alzhanova-Ericsson et al., 1996), and now
also hrp23. Each of these proteins displays its own specific
behavior. The snRNP proteins show a transient associa-
tion with the particle during splicing, while the CBP20 is
added to the 59 end of the transcript early during transcrip-
tion and is not released until the 59 end hits the cytoplasm.
The three hnRNP proteins are all added onto and along
the transcript concomitant with transcription. While hrp36,
an A1-like protein, accompanies the BR RNA through the
pores into cytoplasm and even into polysomes, hrp23 and
hrp45 remain in the nucleus. The hrp23 protein is, how-
ever, clearly shed before or at the binding of the particle to
the pore complex, while hrp45 is not displaced until the
RNP is entering the central channel of the pore complex.
Thus, the two nonshuttling proteins studied are not re-
leased at the same time in conjunction with the transloca-
tion of the BR particle through the nuclear pore, but do so
in a consecutive fashion beginning before or at the binding
of the particle to the nuclear pore complex. The finding
that the BR RNA-binding proteins hrp23, hrp36, and
hrp45 behave differently during nucleocytoplasmic trans-
port suggests that each of them could play a specific role
during the export of mRNA from the nucleus to the cyto-
plasm.
hrp23 Appears in the Nucleolus
It was surprising to find that the hrp23 protein is present in
the nucleolus. It resides evidently both in the fibrillar and
granular regions of the nucleolus. One hnRNP protein,
hnRNP I, has earlier been detected in a discrete perinucle-
olar region (Ghetti et al., 1992), but hrp23 is the first
hnRNP protein found to be located within the nucleolus.
As the hrp23 immunolabeling was shown to be sensitive to
RNase, it is likely that hrp23 is associated with RNA. One
possibility would be that hrp23 is bound to ribosomal
RNA, either one or more of the RNA species generated in
the nucleolus or 5S RNA transported from the site of syn-
thesis to the nucleolus. A second possibility would be that
hrp23 is coupled to a nonribosomal RNA species. Typical,
DRB-sensitive hnRNA has not been recorded in the nu-
cleolus, but a rapidly labeled, DRB-insensitive, heterodis-
perse RNA in the 20–30 S size range has been revealed
(Ringborg et al., 1970). If this specific type of putative
hnRNA would be associated with hrp23, neither hrp36 nor
hrp45 would be part of the RNP complex. Such a nucleo-
lus-located hnRNP complex would then be a striking ex-
ample of the concept that each type of hnRNP particle
contains a specific subset of hnRNP proteins (Matunis et al.,
1993; Wurtz et al., 1996).
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